APEN News and Press, Apollo Endosurgery Inc. From 10/25/19

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the third quarter ended September 30, 2019 on Wednesday, Octob...

Gainers:  Asure Software (NASDAQ: ASUR ) +22% . SunLink Health Systems (NYSEMKT: SSY ) +10% . AgeX Therapeutics (NYSEMKT: AGE ) +9% . NIO (NYSE: NIO ) +9% . ATIF Holdings (NASDAQ: ATIF ) +8% . Frontier Communications Corporation (NASDAQ: FTR ) +8% . Nordic American Tankers Limit...

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Polypropylene Suture-Anchor...

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it has closed its previously announced private placement of $20 million of unsecured convertible debentures to ...

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it has entered into definitive agreements with accredited investors, including officers and affiliates of certa...

Apollo Endosurgery, Inc. (APEN) Q2 2019 Earnings Conference Call July 23, 2019 04:30 PM ET Company Participants John Gillings - Investor Relations Todd Newton - Chief Executive Officer Stefanie Cavanaugh - Chief Financial Officer Conference Call Participants Matt Hewitt - C...

Apollo Endosurgery (NASDAQ: APEN ): Q2 GAAP EPS of -$0.40 misses by $0.02 . More news on: Apollo Endosurgery, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter ended Jun...

NEW YORK, NY / ACCESSWIRE / July 23, 2019 / Apollo Endosurgery, Inc. (NASDAQ: APEN ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 23, 2019 at 4:30 PM Eastern Time. To listen to the event live or access a replay of the call - visit ht...

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended June 30, 2019 on Tuesday,...